Cargando…

Validation of Motor Outcome Measures in Myotonic Dystrophy Type 2

Introduction: Myotonic dystrophy type 2 (DM2) lacks disease-specific, validated, motor outcome measures (OMs), and patients' reported outcomes (PROs). This represents a limit for the monitoring of disease progression and treatment response. Our aim was to identify the most appropriate OMs to be...

Descripción completa

Detalles Bibliográficos
Autores principales: Montagnese, Federica, Rastelli, Emanuele, Khizanishvili, Nina, Massa, Roberto, Stahl, Kristina, Schoser, Benedikt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186332/
https://www.ncbi.nlm.nih.gov/pubmed/32373059
http://dx.doi.org/10.3389/fneur.2020.00306